Expression of TRAIL receptors in human hepatocellular carcinoma and apoptosis induced by TRAIL

Chinese-German Journal of Clinical Oncology

Volumn 2, Issue 3, 2003, Pages 140-144

  Ge, Ruitiang ^a   Shen, Feng ^a   Wu, McNgch ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Hepatocellular carcinoma; The receptors of tumor necrosis factor relatedapoptosiss induing ligand

Indexed keywords

EID: 33846440969     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/BF02842285     Document Type: Article

References (28)

1. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell, 1994, 78: 539-542.
2. Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer, 1994, 73: 2013-2026.
3. Steller H. Mechanism and genes of cellular suicide. Science, 1995, 267: 1445-1449.
4. Nagata S. Apoptosis by death factor. Cell, 1997, 88: 355-365.
5. Havell EA, Fiefs S, North RJ. The antitumor function of tumor necrosis factor (TNF).I.Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J Exp Med, 1988, 167: 1067-1085.
6. Ogasawara J, WatanabeFhkunafa R, Adachi M, et al. Lethal effect of the anti-Fas antibody in mice. Nature, 1993, 364: 806-809.
7. Wiley SR, Sehooley K, Smolak P J, et al. Identification and characterization of a new member of the TNF family that induce s apoptosis. Immunity, 1995, 3:673 682.
8. Pitti RM, Marsters SA, Ruppert S, et al, Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem, 1996, 271: 12687 12690.
9. Pan G, O' Rourke K, Chinnaiyan AM, et al. The receptor for the cytotoxie ligand TRAIL. Science, 1997, 276: 111-113.
10. Schneider P, Thome M, Burns K, et al. TRAIL receptor 1(DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-B. Immunity, 1997, 7: 831-836.
11. Walczak H, Degli Esposti MA, Johnson RS, et al. TRAILR2: a novel apoptosismediating receptor for TRAIL. EMBO J, 1997, 16: 5386-5397.
12. Degli Esposti MA, Smolak P J, Walczak H, et al. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med, 1997, 186: 1165-1170.
13. Pan G, Ni J, YU G, et al. TRUND, a new member of the TRAIL receptor family that antagonizes TRAIL signaling. FEBS Lett, 1988, 424: 41-45.
14. Gazitt Y. TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells. Leukemia, 1999, 13: 181-1824.
15. Thomas WD, Hersy P. TNF-related apoptosis-inducing ligand (TRAIL) induces apotosis in Fas ligand-resistant melanoma cells and mediates in CD4 T cell killing of target cells. J Immunol, 1998, 161: 2195-2200.
16. Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor related apoptosis-inducing ligand in vivo. Nat Med, 1999, 5: 157-163.
17. Sugimoto K, Shiraki K, Ito T, et al. Expression of functional CD40 in human hepato-cellular carcinoma. Hepatology, 1999, 30: 920-926.
18. Natoli G, Ianni A, Costanzo A, et al. Resistance to Fasmediated apoptosis in human hepatoma cells. Oncogene, 1995, 11: 115-1164.
19. Zhang XD, Franco AV, Nguyen T, et al. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human milanoma cells. J Immuno, 2000, 164: 3961-3970.
20. Langaas V, Shahzidi S, Johnson JI, et al. Interferon gamma modulates TRAIL-mediated apoptosis in human colon carcinoma cells. Anticancer Res, 2001, 21: 3733-3738.
21. Ben Jilani KE, -kkarid K, Arnoult D, et al. Gammainterferon induces apoptosis of the B lymphoma WEHI-279 cell line through a CD95/CD95L-independent mechanism. Eur Cytokine Netw, 2001, 12: 587-596.
22. Chawla Sarkar M, Leaman DW, Borden EC. Preferential induction of apoptosis by interferon (IFN)-beta compared with IFN-alpha2: correlation with TRAIL/Apo2L induction in melanoma cell lines. Clin Cancer Res, 2001, 7:1821-1831.
23. Park SY, Billiar TR, Seol DW. IFN-gamma inhibition of TRAIL-induced IAP-2 upregulation, a possible mechanism of IFN-gamma-enhanced TRAIL-induced apoptosis. Biochem Biophys Res Commun, 2002, 291: 233-236.
24. Kumar Sinha G, Varambolly S, Sreckumar A, et al. Molecular cross-talk between the TRAIL and interferon signaling pathways. J Biol Chem, 2002, 277:575-585.
25. Shin EC, Ahn JM, Kim CH, et al. IFN-gamma induces cell death in human hepatoma cells through a TRAIL/death receptor-mediated apoptotic pathway. Int J Cancer, 2001, 93: 262-268.
26. Park SY, Billiar TR, Seol DW. IFN-gamma inhibition of TRAIL-induced IAP-2 upregulation, a possible mechanism of IFN-gamma-enhanced TRAIL-induced apoptosis. Biochem Biophys Res Commun, 2002, 291: 233-236.
27. Ruiz-Ruiz C, Lopez Rivas A. Mitochondria-dependent and-independent mechanisms in tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL)-induced apoptosis are both regulated by interferon-(gamma) in human breast tumor cells. Biochem J, 2002, 365:825-832.
28. Jo M, Kim TH, Seol DW, et al. Apoptosis induced in normal human hepatocytos by turner necrosis factor-releated apoptosis-induing ligand. Nat Med, 2000, 6: 564-567.